Given the therapeutic potential of GCPII inhibition for cognitive disorders, the current study also examined the effects of local vs. systemic GCPII inhibition on dlPFC neuronal firing and working memory performance, respectively, in aged rhesus monkeys. The gene discussed is FOLH1; the disease is cognitive disorder.